Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Exelixis Inc. (EXEL)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: EXEL
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on EXEL
Ohad Hammer
(175 followers)
Top Biotech Picks for ASCO 2009 (Part II)
(Wed, May 27)
Top Biotech Picks for ASCO 2009 (Part I)
(Wed, May 27)
Micromet: More Reasons for Optimism
(Mon, May 11)
More by Ohad Hammer on EXEL »
Travis Johnson
(24 followers)
Four Conviction Buys for Our Age of Uncertainty
(Mon, Mar 19)
Exelixis' Special Purpose Entities A Far Cry From Enron (EXEL)
(Tue, Apr 11)
Exelixis Upgraded With Good Reason (EXEL)
(Wed, Mar 29)
More by Travis Johnson on EXEL »
Alan Brochstein
(707 followers)
Cancer Stocks: Tracking the Market
(Mon, Jul 9)
Cancer Stocks: The Bleeding Slows
(Mon, Jul 2)
Cancer Stocks Hammered Once Again
(Tue, Jun 26)
More by Alan Brochstein on EXEL »
Most followed authors on EXEL
SA Editor Rachael Granby
(2020 followers)
Wall Street Breakfast: Must-Know News
(Fri, Jul 31)
More by SA Editor Rachael Granby on EXEL »
Mike Havrilla
(1924 followers)
ImmunoCellular's Promising Brain Cancer Vaccine
(Wed, Oct 28)
Small Cap Stocks Battling Brain Cancer
(Mon, Sep 7)
40 Top Rated Emerging Bio-Pharma Stocks
(Tue, Dec 23)
More by Mike Havrilla on EXEL »
Marco Hickey
(1311 followers)
Breakout Stocks on Huge Volume: Three Option Trades
(Mon, Jul 27)
More by Marco Hickey on EXEL »
Newest authors on EXEL
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on EXEL »
The Burrill Report
(192 followers)
Two Potential Mega Biotech Deals Fuel Industry Hopes
(Sun, May 31)
Exelixis Suggests Creativity in Finding Cash for Biotechs in Rough Times
(Tue, May 26)
More by The Burrill Report on EXEL »
Marco Hickey
(1311 followers)
Breakout Stocks on Huge Volume: Three Option Trades
(Mon, Jul 27)
More by Marco Hickey on EXEL »
Most commented on EXEL
Ohad Hammer
(175 followers)
Top Biotech Picks for ASCO 2009 (Part II)
(Wed, May 27)
Top Biotech Picks for ASCO 2009 (Part I)
(Wed, May 27)
Micromet: More Reasons for Optimism
(Mon, May 11)
More by Ohad Hammer on EXEL »
Justin M. Hall
(672 followers)
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
(Sun, Sep 20)
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
(Fri, Sep 11)
More by Justin M. Hall on EXEL »
SA Editor Rachael Granby
(2020 followers)
Wall Street Breakfast: Must-Know News
(Fri, Jul 31)
More by SA Editor Rachael Granby on EXEL »